PINK1 function in health and disease

EMBO Molecular Medicine

Volumn 1, Issue 3, 2009, Pages 152-165

  Deas, Emma ^a   Plun Faureau, Helene ^a   Wood, Nicholas W ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Calcium signalling; Mitochondria; Oxidative stress; PINK1

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; ADENOSINE TRIPHOSPHATE; ANTIOXIDANT; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CALCIUM; CALCIUM CHANNEL; CHAPERONE; CYTOCHROME C; DJ 1 PROTEIN; DNA; DOPAMINE RECEPTOR; FREE RADICAL; GLUCOSE TRANSPORTER; GREEN FLUORESCENT PROTEIN; PARKIN; PHOSPHATASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEASOME; PROTEIN KINASE; PROTEIN KINASE B; PTEN INDUCED KINASE 1; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; SODIUM CHANNEL; TENSIN; TRANSCRIPTION FACTOR FKHRL1; UBIQUITIN; UNCLASSIFIED DRUG;

ADULT; APOPTOSIS; AUTOPHAGY; BRAIN TISSUE; BREATHING; CALCIUM SIGNALING; CALCIUM TRANSPORT; CANCER CELL; CASE REPORT; CELL CULTURE; CELL CYCLE; CELL FRACTIONATION; CELL FUSION; CELL LEVEL; CELL LINE; CELL MEMBRANE PERMEABILITY; CELL MIGRATION; CELL MOTILITY; CELL NUCLEUS; CELL ORGANELLE; CELL PROTECTION; CELL STRUCTURE; CELL VACUOLE; CELLULAR DISTRIBUTION; COMPLEX I DEFICIENCY; CYTOSOL; DEGENERATIVE DISEASE; DOPAMINERGIC NERVE CELL; DOWN REGULATION; DROSOPHILA; ENERGY RESOURCE; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME SUBSTRATE; FIBROBLAST; GEL ELECTROPHORESIS; GENETIC COMPLEMENTATION; GLUCOSE METABOLISM; HUMAN; HYDROLYSIS; IMMUNE SYSTEM; LYSOSOME; METABOLITE; MICROTUBULE; MITOCHONDRIAL MEMBRANE; MUSCLE FUNCTION; NERVE CELL; NEUROTRANSMITTER RELEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; OXYGEN CONSUMPTION; PARKINSON DISEASE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DEGRADATION; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RESPIRATORY CHAIN; REVIEW; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; SYNAPSE; UBIQUITINATION; UPREGULATION; WILD TYPE; ZEBRA FISH;

ANIMALS; APOPTOSIS; BIOLOGICAL TRANSPORT; CALCIUM SIGNALING; DISEASE MODELS, ANIMAL; DROSOPHILA MELANOGASTER; HUMANS; MICE; MITOCHONDRIA; MODELS, BIOLOGICAL; MUTATION; NEOPLASMS; OXIDATIVE STRESS; PARKINSON DISEASE; PROTEIN FOLDING; PROTEIN KINASES; UBIQUITINATION;

EID: 76149104800     PISSN: 17574676     EISSN: 17574684     Source Type: Journal    
DOI: 10.1002/emmm.200900024     Document Type: Review

References (85)

1. Abou-Sleiman PM, Muqit MM, McDonald NQ, Yang YX, Gandhi S, Healy DG, Harvey K, Harvey RJ, Deas E, Bhatia K, et al(2006) A heterozygous effect for PINK1 mutations in Parkinson's disease? Ann Neurol 60: 414-419
2. Anichtchik O, Diekmann H, Fleming A, Roach A, Goldsmith P, Rubinsztein DC (2008) Loss of PINK1 function affects development and results in neurodegeneration in zebrafish. J Neurosci 28: 8199-8207
3. Balaban RS, Nemoto S, Finkel T (2005) Mitochondria, oxidants, and aging. Cell 120: 483-495
4. Bedford L, Hay D, DevoyA, Paine S, Powe DG, Seth R, Gray T, Topham I, Fone K, Rezvani N, et al(2008) Depletion of 26S proteasomes in mouse brain neurons causes neurodegeneration and Lewy-like inclusions resembling human pale bodies. J Neurosci 28: 8189-8198
5. Bender A, Schwarzkopf RM, McMillan A, Krishnan KJ, Rieder G, Neumann M, ElstnerM,Turnbull DM, KlopstockT (2008) Dopaminergic midbrain neurons are the prime target for mitochondrial DNA deletions. J Neurol 255: 1231-1235
6. Berman SB, Pineda FJ, HardwickJM (2008) Mitochondrial fission and fusion dynamics: the long and short of it. Cell Death Differ 15: 1147-1152
7. Campanella M, Casswell E, Chong S, Farah Z, Wieckowski MR, Abramov AY, Tinker A, Duchen MR (2008) Regulation of mitochondrial structure and function by the F1Fo-ATPase inhibitor protein, IF1. Cell Metab 8: 13-25
8. Chan CS, Guzman JN, Ilijic E, Mercer JN, Rick C, Tkatch T, Meredith GE, Surmeier DJ (2007) 'Rejuvenation' protects neurons in mouse models of Parkinson's disease. Nature 447: 1081-1086
9. Chan DC (2006) Mitochondrial fusion and fission in mammals. Annu Rev Cell Dev Biol 22: 79-99
10. Chen H, Chomyn A, Chan DC (2005) Disruption of fusion results in mitochondrial heterogeneity and dysfunction. J Biol Chem 280: 2618526192
11. Chen H, Detmer SA, Ewald AJ, Griffin EE, Fraser SE, Chan DC (2003) Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development. J Cell Biol 160: 189-200
12. Chinnery PF, Turnbull DM (1999) Mitochondrial DN Aand disease. Lancet 354: I17-I21
13. Clark IE, Dodson MW, Jiang C, Cao JH, Huh JR, Seol JH, Yoo SJ, Hay BA, Guo M (2006) Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin. Nature 441: 1162-1166
14. Dagda RK, Cherra SJ, 3rd, Kulich SM, Tandon A, Park D, Chu CT (2009) Loss of pink1 function promotes mitophagy through effects on oxidative stress and mitochondrial fission. J Biol Chem 284: 13843-13855
15. Dawson TM, Dawson VL (2003) Molecular pathways of neurodegeneration in Parkinson's disease. Science 302: 819-822
16. Deng H, Dodson MW, Huang H, Guo M (2008) The Parkinson's disease genes pink1 and parkin promote mitochondrial fission and/or inhibit fusion in Drosophila. Proc Natl Acad Sci USA 105: 14503-14508
17. Deng H,Jankovic J, Guo Y, Xie W, Le W (2005) Small interfering RNA targeting the PINK1 induces apoptosis in dopaminergic cells SH-SY5Y. Biochem Biophys Res Commun 337: 1133-1138
18. Detmer SA, Chan DC (2007) Functions and dysfunctions of mitochondrial dynamics. Nat Rev Mol Cell Biol 8: 870-879
19. Dexter DT, Carter CJ, Wells FR, Javoy-Agid F, Agid Y, Lees A, Jenner P, Marsden CD (1989) Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J Neurochem 52: 381-389
20. Exner N, Treske B, Paquet D, Holmstrom K, Schiesling C, Gispert S, Carballo- Carbajal I, Berg D, Hoepken HH, Gasser T, et al(2007) Loss-of-function of human PINK1 results in mitochondrial pathology and can be rescued by parkin. J Neurosci 27: 12413-12418
21. Faccio L, Fusco C, Chen A, Martinotti S, Bonventre JV, Zervos AS (2000) Characterization of a novel human serine protease that has extensive homology to bacterial heat shock endoprotease HtrA and is regulated by kidney ischemia. J Biol Chem 275: 2581-2588
22. Fitzgerald JC, Plun-Favreau H (2008) Emerging pathways in genetic Parkinson's disease: autosomal-recessive genes in Parkinson's disease-a common pathway? FEBS J 275: 5758-5766
23. Gandhi S, Muqit MM, Stanyer L, Healy DG, Abou-Sleiman PM, Hargreaves I, Heales S, Ganguly M, Parsons L, Lees AJ, et al(2006) PINK1 protein in normal human brain and Parkinson's disease. Brain 129: 1720-1731
24. Gandhi S, Wood-Kaczmar A, Yao Z, Plun-Favreau H, Deas E, Klupsch K, Downward J, Latchman DS, Tabrizi SJ, Wood NW, et al(2009) PINK1- associated Parkinson's disease is caused by neuronal vulnerability to calcium-induced cell death. Mol Cell 33: 627-638
25. Gao X, Hu H (2008) Quality control of the proteins associated with neurodegenerative diseases. Acta Biochim Biophys Sin (Shanghai) 40: 612-618
26. Gautier CA, Kitada T, Shen J (2008) Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress. Proc Natl Acad Sci USA 105: 11364-11369
27. Gegg ME, Cooper JM, Schapira AH, Taanman JW (2009) Silencing of PINK1 expression affects mitochondrial DNA and oxidative phosphorylation in dopaminergic cells. PLoS ONE 4: e4756
28. Germain D (2008) Ubiquitin-dependent and -independent mitochondrial protein quality controls: implications in ageing and neurodegenerative diseases. Mol Microbiol 70: 1334-1341
29. Haque ME, Thomas KJ, D'Souza C, Callaghan S, Kitada T, Slack RS, Fraser P, Cookson MR, Tandon A, Park DS (2008) Cytoplasmic Pink1 activity protects neurons from dopaminergic neurotoxin MPTP. Proc Natl Acad Sci USA 105: 1716-1721
30. Hoepken HH, Gispert S, Morales B, Wingerter O, Del Turco D, Mulsch A, Nussbaum RL, Muller K, Drose S, Brandt U, et al(2007) Mitochondrial dysfunction, peroxidation damage and changes in glutathione metabolism in PARK6. Neurobiol Dis 25: 401-411
31. Hollenbeck PJ, Saxton WM (2005) The axonal transport of mitochondria. J Cell Sci 118: 5411-5419
32. Inzelberg R, Jankovic J (2007) Are Parkinson disease patients protected from some but not all cancers? Neurology 69: 1542-1550
33. Kabbani N, Negyessy L, Lin R,Goldman-Rakic P, Levenson R (2002) Interaction with neuronal calcium sensor NCS-1 mediates desensitization of the D2 dopamine receptor. J Neurosci 22: 8476-8486
34. Kitada T, Pisani A, Porter DR, Yamaguchi H, Tscherter A, Martella G, Bonsi P, Zhang C, Pothos EN, Shen J (2007) Impaired dopamine release and synaptic plasticity in the striatum of PINK1-deficient mice. Proc Natl Acad Sci USA 104: 11441-11446
35. Langston JW, Ballard P, Tetrud JW, Irwin I (1983) Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219: 979-980
36. Langston JW, Ballard PA Jr. (1983) Parkinson's disease in a chemist working with 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. N Engl J Med 309: 310
37. Li W, Bengtson MH, Ulbrich A, Matsuda A, Reddy VA, Orth A, Chanda SK, Batalov S, Joazeiro CA (2008) Genome-wide and functional annotation of human E3 ubiquitin ligases identifies MULAN, a mitochondrial E3 that regulates the organelle's dynamics and signaling. PLoS ONE 3: e1487
38. Liu W, Vives-Bauza C, Acin-Perez R, Yamamoto A, Tan Y, Li Y, Magrane J, Stavarache MA, Shaffer S, Chang S, et al(2009) PINK1 defect causes mitochondrial dysfunction, proteasomal deficit and alpha-synuclein aggregation in cell culture models of Parkinson's disease. PLoS ONE 4: e4597
39. MacKeigan JP, Murphy LO, Blenis J (2005) Sensitized RNAi screen of human kinases and phosphatases identifies new regulators of apoptosis and chemoresistance. Nat Cell Biol 7: 591-600
40. Marongiu R, Spencer B, Crews L, Adame A, Patrick C, Trejo M, Dallapiccola B, Valente EM, Masliah E (2009) Mutant Pink1 induces mitochondrial dysfunction in a neuronal cell model of Parkinson's disease by disturbing calcium flux. J Neurochem 103: 1561-1574
41. Mei Y, Zhang Y, Yamamoto K, Xie W, Mak TW, You H (2009) FOXO3a- dependent regulation of Pink1 (Park6) mediates survival signaling in response to cytokine deprivation. Proc Natl Acad Sci USA 106: 5153-5158
42. Mills RD, Sim CH, Mok SS, Mulhern TD, Culvenor JG, Cheng HC (2008) Biochemical aspects of the neuroprotective mechanism of PTEN-induced kinase-1 (PINK1). J Neurochem 105: 18-33
43. Morais VA, Verstreken P, Roething A, Smet J, Snellinx A, Vanbrabant M, Haddad D, Frezza C, Mandemakers W, Vogt-Weisenhorn D, et al(2009) Parkinson's disease mutations in PINK1 result in decreased Complex I activity and deficient synaptic function. EMBO Mol Med 1: 1-13
44. Moriwaki Y, Kim YJ, Ido Y, Misawa H, Kawashima K, Endo S,Takahashi R (2008) L347P PINK1 mutant that fails to bind to Hsp90/Cdc37 chaperones is rapidly degraded in a proteasome-dependent manner. Neurosci Res 61: 43-48
45. Mortiboys H, Thomas KJ, Koopman WJ, Klaffke S, Abou-Sleiman P, Olpin S, Wood NW, Willems PH,SmeitinkJA,Cookson MR, et al(2008) Mitochondrial function and morphology are impaired in parkin-mutant fibroblasts. Ann Neurol 64: 555-565
46. Muqit MM, Abou-Sleiman PM, Saurin AT, Harvey K, Gandhi S, Deas E, Eaton S, Payne Smith MD, Venner K, Matilla A, et al(2006) Altered cleavage and localization of PINK1 to aggresomes in the presence of proteasomal stress. J Neurochem 98: 156-169
47. Nakamura N, Kimura Y, Tokuda M, Honda S, Hirose S (2006a) MARCH-V is a novel mitofusin 2- and Drp1-binding protein able to change mitochondrial morphology. EMBO Rep 7: 1019-1022
48. Nakamura TY, Jeromin A, Smith G, Kurushima H, Koga H, Nakabeppu Y, Wakabayashi S, Nabekura J (2006b) Novel role of neuronal Ca2+ sensor-1 as a survival factor up-regulated in injured neurons. J Cell Biol 172: 1081-1091
49. Olanow CW, McNaught KS (2006) Ubiquitin-proteasome system and Parkinson's disease. Mov Disord 21: 1806-1823
50. Park J, Lee G, Chung J (2009) The PINK1-Parkin pathway is involved in the regulation of mitochondrial remodeling process. Biochem Biophys Res Commun 378: 518-523
51. Park J, Lee SB, Lee S, Kim Y, Song S, Kim S, Bae E, Kim J, Shong M, Kim JM, et al (2006) Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin. Nature 441: 1157-1161
52. Petit A, Kawarai T, Paitel E, Sanjo N, Maj M, Scheid M, Chen F, Gu Y, Hasegawa H, Salehi-Rad S, et al(2005) Wild-type PINK1 prevents basal and induced neuronal apoptosis, a protective effect abrogated by Parkinson disease-related mutations. J Biol Chem 280: 34025-34032
53. Petko JA, Kabbani N, Frey C, Woll M, Hickey K, Craig M, Canfield VA, Levenson R (2009) Proteomic and functional analysis of NCS-1 binding proteins reveals novel signaling pathways required for inner ear development in zebrafish. vBMC Neurosci 10: 27
54. Piccoli C, Ripoli M, Quarato G, Scrima R, D'Aprile A, Boffoli D, Margaglione M, Criscuolo C, De Michele G, Sardanelli A, et al(2008a) Coexistence of mutations in PINK1 and mitochondrial DNA in early onset Parkinsonism. J Med Genet 33: 2565-2574
55. Piccoli C, Sardanelli A, Scrima R, Ripoli M, Quarato G, D'Aprile A, Bellomo F, Scacco S, De Michele G, Filla A, et al(2008b) Mitochondrial respiratory dysfunction in familiar Parkinsonism associated with PINK1 mutation. Neurochem Res 45: 596-602
56. Plun-Favreau H, Hardy J (2008) PINK1 in mitochondrial function. Proc Natl Acad Sci USA 105: 11041-11042
57. Plun-Favreau H, Klupsch K, Moisoi N, Gandhi S, KjaerS, Frith D, Harvey K, Deas E, Harvey RJ, McDonald N, et al(2007) The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1. Nat Cell Biol 9: 1243-1252
58. Pongs O, Lindemeier J, Zhu XR, Theil T, Engelkamp D, Krah-Jentgens I, Lambrecht HG, Koch KW, SchwemerJ, Rivosecchi R, etal(1993) Frequenin-a novel calcium-binding protein that modulates synaptic efficacy in the Drosophila nervous system. Neuron 11: 15-28
59. Poole AC, Thomas RE, Andrews LA, McBride HM, Whitworth AJ, Pallanck LJ (2008) The PINK1/Parkin pathway regulates mitochondrial morphology. Proc Natl Acad Sci USA 105: 1638-1643
60. Pridgeon JW, Olzmann JA, Chin LS, Li L(2007) PINK1 Protects against oxidative stress by phosphorylating mitochondrial chaperone TRAP1. PLoS Biol 5: e172
61. Radke S, Chander H, Schafer P, Meiss G, Kruger R, Schulz JB, Germain D (2008) Mitochondrial protein quality control by the proteasome involves ubiquitination and the protease Omi. J Biol Chem 283: 12681-12685
62. Rousset M, Cens T, Gavarini S, Jeromin A, Charnet P (2003) Down-regulation of voltage-gated Ca2+ channels by neuronal calcium sensor-1 is beta subunit-specific. J Biol Chem 278: 7019-7026
63. Saotome M, Safiulina D, Szabadkai G, Das S, Fransson A, Aspenstrom P, Rizzuto R, Hajnoczky G (2008) Bidirectional Ca2+-dependent control of mitochondrial dynamics by the Miro GTPase. Proc Natl Acad Sci USA 105: 20728-20733
64. Schapira AH, Cooper JM, Dexter D, Jenner P, Clark JB, Marsden CD (1989) Mitochondrial complex I deficiency in Parkinson's disease. Lancet 1: 1269
65. Scheele C, Nielsen AR, Walden TB, Sewell DA, FischerCP, Brogan RJ, Petrovic N, Larsson O, Tesch PA, Wennmalm K, et al(2007) Altered regulation of the PINK1 locus: a link between type 2 diabetes and neurodegeneration? FASEB J 21: 3653-3665
66. Shults CW, Haas R (2005) Clinical trials of coenzyme Q10 in neurological disorders. Biofactors 25: 117-126
67. Siddall HK, Warrell CE, Davidson SM, Mocanu MM, Yellon DM (2008) Mitochondrial PINK1-a novel cardioprotective kinase? Cardiovasc Drugs Ther 22: 507-508
68. Spiess C, Beil A, Ehrmann M (1999) A temperature-dependent switch from chaperone to protease in a widely conserved heat shock protein. Cell 97: 339-347
69. Storch A, Jost WH, Vieregge P, Spiegel J, Greulich W, Durner J, Muller T, Kupsch A, Henningsen H, Oertel WH, et al(2007) Randomized, double-blind, placebo-controlled trial on symptomatic effects of coenzyme Q(10) in Parkinson disease. Arch Neurol 64: 938-944
70. Twig G, Elorza A, Molina AJ, Mohamed H, Wikstrom JD, WalzerG, Stiles L, Haigh SE, Katz S, Las G, et al(2008) Fission and selective fusion govern mitochondrial segregation and elimination by autophagy. EMBO J 27: 433-446
71. Unoki M, Nakamura Y (2001) Growth-suppressive effects of BPOZ and EGR2, two genes involved in the PTEN signaling pathway. Oncogene 20: 4457-4465
72. Valente EM, Abou-Sleiman PM, Caputo V, Muqit MM, Harvey K, Gispert S, Ali Z, Del Turco D, Bentivoglio AR, Healy DG, et al(2004) Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 304: 1158-1160
73. Walsh NP, Alba BM, Bose B, Gross CA, Sauer RT (2003) OMP peptide signals initiate the envelope-stress response by activating DegS protease via relief of inhibition mediated by its PDZ domain. Cell 113: 61-71
74. Wang D, Qian L, Xiong H, Liu J, Neckameyer WS, Oldham S, Xia K, Wang J, Bodmer R, Zhang Z (2006) Antioxidants protect PINK1-dependent dopaminergic neurons in Drosophila. Proc Natl Acad Sci USA 103: 13520-13525
75. Wang X, Schwarz TL (2009) The mechanism of Ca2+ -dependent regulation of kinesin-mediated mitochondrial motility. Cell 136: 163-174
76. Weihofen A, Ostaszewski B, Minami Y, Selkoe DJ (2008) Pink1 Parkinson mutations, the Cdc37/Hsp90 chaperones and Parkin all influence the maturation or subcellular distribution of Pink1. Hum Mol Genet 17: 602-616
77. Weihofen A, Thomas KJ, Ostaszewski BL, Cookson MR, Selkoe DJ (2009) Pink1 forms a multiprotein complex with Miro and Milton, linking Pink1 function to mitochondrial trafficking (dagger). Biochemistry 48: 2045-2052
78. Westermann B (2008) Molecular machinery of mitochondrial fusion and fission. J Biol Chem 283: 13501-13505
79. Wood-Kaczmar A, Gandhi S, Yao Z, Abramov AS, Miljan EA, Keen G, Stanyer L, Hargreaves I, Klupsch K, Deas E, etal(2008) PINK1 is necessary for long term survival and mitochondrial function in human dopaminergic neurons. PLoS ONE 3: e2455
80. Wu DC, Teismann P, Tieu K, Vila M, Jackson-Lewis V, Ischiropoulos H, Przedborski S (2003) NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease. Proc Natl Acad Sci USA 100: 6145-6150
81. Yang Y, Gehrke S, Imai Y, Huang Z, Ouyang Y, Wang JW, Yang L, Beal MF, Vogel H, Lu B (2006) Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by Parkin. Proc Natl Acad Sci USA 103: 10793-10798
82. Yang Y, Ouyang Y, Yang L, Beal MF, McQuibban A, Vogel H, Lu B (2008) Pink1 regulates mitochondrial dynamics through interaction with the fission/fusion machinery. Proc Natl Acad Sci USA 105: 7070-7075
83. Yonashiro R, Ishido S, Kyo S, Fukuda T, Goto E, Matsuki Y, Ohmura-Hoshino M, Sada K, Hotta H, Yamamura H, et al(2006) A novel mitochondrial ubiquitin ligase plays a critical role in mitochondrial dynamics. EMBO J 25: 3618-3626
84. Zhou C, Huang Y, Przedborski S (2008a) Oxidative stress in Parkinson's disease: a mechanism of pathogenic and therapeutic significance. Ann N Y Acad Sci 1147: 93-104
85. Zhou C, Huang Y, Shao Y, May J, Prou D, Perier C, Dauer W, Schon EA, Przedborski S (2008b) The kinase domain ofmitochondrial PINK1 faces the cytoplasm. Proc Natl Acad Sci USA 105: 12022-12027